These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8596630)

  • 1. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
    Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
    Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation.
    Li V; Raouf A; Kitching R; Seth A
    In Vivo; 2004; 18(5):517-24. PubMed ID: 15523888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome.
    Sanij E; Hatzistavrou T; Hertzog P; Kola I; Wolvetang EJ
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1003-8. PubMed ID: 11573964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice.
    Neznanov N; Man AK; Yamamoto H; Hauser CA; Cardiff RD; Oshima RG
    Cancer Res; 1999 Sep; 59(17):4242-6. PubMed ID: 10485465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.
    Wolvetang EJ; Bradfield OM; Hatzistavrou T; Crack PJ; Busciglio J; Kola I; Hertzog PJ
    Neurobiol Dis; 2003 Dec; 14(3):349-56. PubMed ID: 14678752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
    Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
    Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
    Wolvetang EW; Bradfield OM; Tymms M; Zavarsek S; Hatzistavrou T; Kola I; Hertzog PJ
    Biochim Biophys Acta; 2003 Jul; 1628(2):105-10. PubMed ID: 12890557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
    Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
    Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of ETS genes induced by electromagnetic fields.
    Mucci N; Ianni A; Ursini CL; Arzani D; Bhat NK; Navarra P; Romano-Spica V
    In Vivo; 2001; 15(6):489-94. PubMed ID: 11887334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
    Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
    J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.
    Wolvetang EJ; Wilson TJ; Sanij E; Busciglio J; Hatzistavrou T; Seth A; Hertzog PJ; Kola I
    Hum Mol Genet; 2003 Feb; 12(3):247-55. PubMed ID: 12554679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic deficiencies and core binding factor expression in murine Ts16, an animal model for Down syndrome.
    Gjertson C; Sturm KS; Berger CN
    Clin Immunol; 1999 Apr; 91(1):50-60. PubMed ID: 10219254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells.
    Sapi E; Flick MB; Rodov S; Kacinski BM
    Cancer Res; 1998 Mar; 58(5):1027-33. PubMed ID: 9500466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene for porcine pregnancy-associated glycoprotein 2 (poPAG2): its structural organization and analysis of its promoter.
    Szafranska B; Miura R; Ghosh D; Ezashi T; Xie S; Roberts RM; Green JA
    Mol Reprod Dev; 2001 Oct; 60(2):137-46. PubMed ID: 11553911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer.
    Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR; Seth A; Rosenberg M; Papas T; Debouck C; Kola I
    Oncogene; 1997 Nov; 15(20):2449-62. PubMed ID: 9395241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.